Skip to content

palonosetron intravenous

Interactions

Quinidine; Natisedine/Selected QT Prolongers

This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.

Medical warning:

Moderate. These medicines may cause some risk when taken together. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.

How the interaction occurs:

Quinidine, which is also a component of natisedine, can affect your heart's rhythm. Other drugs can have the same effect.

What might happen:

Taking quinidine or natisedine with other agents that can affect your heart rhythm may increase your risk of an irregular heartbeat, which may be life-threatening.

What you should do about this interaction:

Let your healthcare professionals (e.g doctor or pharmacist) know that you are taking these medications together. Your doctor may want to perform an electrocardiogram (ECG) on you to check your heart's rhythm. Let your doctor know right away if you notice an irregular heartbeat or have any dizziness or fainting episodes.Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.

References:

1.Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, Philippides GJ, Roden DM, Zareba W. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2010 Mar 2;55(9):934-47.

2.Uroxatral (alfuzosin hydrochloride) US prescribing information. Sanofi-Synthelabo, Inc. May, 2013.

3.Apokyn (apomorphine hydrochloride) US prescribing information. Tercica, Inc. July, 2010.

4.Clozaril (clozapine tablets) US prescribing information. Novartis Pharmaceuticals Corporation March, 2013.

5.Sprycel (dasatinib) US prescribing information. Bristol-Myers Squibb Company June, 2013.

6.Anzemet (dolasetron mesylate) US prescribing information. Sanofi-Aventis Us.S. LLC September, 2014.

7.Mathivanan M. Dear Canadian Healthcare Professional: Subject: Association of domperidone maleate with serious ventricular arrhythmias and sudden cardiac death. Teva Canada Limited March 2, 2012.

8.Toviaz (fesoterodine) UK summary of product characteristics. Pfizer Limited February, 2011.

9.Foradil Aerolizer (formoterol fumarate) US prescribing information. Schering Corporation September, 2012.

10.Symbicort Turbuhaler (budesonide-eformoterol fumarate dihydrate) Australian prescribing information. AstraZeneca Pty Ltd April 30, 2004.

11.Primovist (gadoxetate disodium) Australian prescribing information. Schering-Plough Corporation November 1, 2005.

12.Primovist (gadoxetic acid) UK summary of product characteristics. Bayer plc May 1, 2008.

13.Serenace (haloperidol) Australian prescribing information. Sigma Pharmaceuticals Pty Ltd. June 5, 2001.

14.Dozic (haloperidol) UK summary of product characteristics. Rosemont Pharmaceuticals Limited September 10, 2007.

15.Haldol (haloperidol) US prescribing information. Ortho-McNeil-Janssen Pharmaceuticals, Inc. August, 2011.

16.Tykerb (lapatinib) US prescribing information. GlaxoSmithKline October, 2013.

17.Dolophine (methadone hydrochloride) US prescribing information. Roxane Laboratories, Inc. July, 2012.

18.Votrient (pazopanib) US prescribing information. GlaxoSmithKline June, 2014.

19.Edurant (rilpivirine) US prescribing information. Tibotec Pharmaceuticals June, 2013.

20.Risperidal (risperidone) UK summary of product characteristics. Janssen-Cilag, UK Limited May 14, 2004.

21.Zolinza (vorinostat) US prescribing information. Merck & Co., Inc. 2006.

22.Plenaxis (abarelix) US prescribing information. Praecis Pharmaceuticals Incorporated November, 2003.

23.Trisenox (arsenic trioxide) US prescribing information. Cell Therapeutics, Inc. March, 2001.

24.Sirturo (bedaquiline) US prescribing information. Janssen Therapeutics August, 2013.

25.Zykadia (ceritinib) US prescribing information. Novartis Pharmaceuticals Corporation April, 2014.

26.Cipro (ciprofloxacin hydrochloride) US prescribing information. Bayer Corporation August, 2013.

27.Ciproxin (ciprofloxacin hydrochloride) UK summary of product characteristics. Bayer plc April 13, 2010.

28.Xalkori (crizotinib) US prescribing information. Pfizer Inc. November, 2013.

29.Halaven (eribulin mesylate) US prescribing information. Eisai, Inc. August, 2014.

30.Lexapro (escitalopram oxalate) US prescribing information. Forest Pharmaceuticals Inc. December, 2012.

31.USFood and Drug Administration. FDA Drug Safety Communication: Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm297391.htm March 28, 2012.

32.Health Canada. Antidepressant Cipralex (escitalopram): Updated information regarding dose-related heart risk. Available at: http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2012/136 74a-eng.php May 7, 2012.

33.Cipralex (escitalopram oxalate) Canadian prescribing information. Lundbeck August 13, 2012.

34.Cipralex (escitalopram oxalate) UK summary of product characteristics. Lunbeck Limited September 14, 2012.

35.Trobalt (retigabine) UK summary of product characteristics. GlaxoSmithKline UK March 28, 2011.

36.Ablavar (gadofosveset trisodium) US prescribing information. Lantheus Medical Imaging, Inc. August, 2013.

37.Zofran (ondansetron) US prescribing information. GlaxoSmithKline September, 2014.

38.USFood and Drug Administration. FDA Drug Safety Communication: Abnormal heart rhythms may be associated with use of Zofran (ondansetron). available at: http://www.fda.gov/Drugs/DrugSafety/ucm271913.htm September 15, 2011.

39.Signifor (pasireotide diasparate) US prescribing information. Novartis Pharmaceuticals Corporation December, 2012.

40.Seroquel (quetiapine fumarate) US prescribing information. AstraZeneca Pharmaceuticals LP July, 2011.

41.Istodax (romidepsin) US prescribing information. Celgene Corporation June, 2013.

42.Nexavar (sorafenib) US prescribing information. Bayer Pharmaceuticals Corporation November, 2013.

43.Betapace (sotalol hydrochloride) US prescribing information. Berlex Laboratories August, 2011.

44.Sutent (sunitinib malate) US prescribing information. Pfizer Inc. August, 2013.

45.Vibativ (telavancin) US prescribing information. Astellas Pharma US, Inc. September, 2009.

46.Detrol LA (tolterodine tartrate) US prescribing information. Pharmacia & Upjohn Company September, 2008.

47.Zelboraf (vemurafenib) US Prescribing Information. Hoffman-La Roche March, 2014.

48.The University of Arizona Center for Education and Research of Therapeutics. Drugs with Risk of Torsades de Pointes and Drugs with Possible Risk of Torsades de Pointes. Available at:http://www.crediblemeds.org/. Updated March 14, 2013.

49.Phansalkar S, Desai AA, Bell D, Yoshida E, Doole J, Czochanski M, Middleton B, Bates DW. High-priority drug-drug interactions for use in electronic health records. J Am Med Inform Assoc 2012 Sep-Oct; 19(5):735-43.

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, expect as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.

More about Drugs and Medications

Newsletters

Subscribe to free WebMD newsletters.

  • WebMD Daily

    WebMD Daily

    Subscribe to the WebMD Daily, and you'll get today's top health news and trending topics, and the latest and best information from WebMD.

  • Men's Health

    Men's Health

    Subscribe to the Men's Health newsletter for the latest on disease prevention, fitness, sex, nutrition, and more from WebMD.

  • Women's Health

    Women's Health

    Subscribe to the Women's Health newsletter for the latest on disease prevention, fitness, sex, diet, anti-aging, and more from WebMD.

By clicking Submit, I agree to the WebMD Terms & Conditions & Privacy Policy

URAC: Accredited Health Web Site TRUSTe online privacy certification HONcode Seal AdChoices